#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Neuronal ceroid lipofuscinosis Chronic graft versus host disease Arrhythmogenic right ventricular dysplasia Acute promyelocytic leukaemia Haemophilia A with anti factor VIII Von Willebrand's disease Thyroid cancer metastatic ABO haemolytic disease of newborn Hypertriglyceridaemia Intracranial germ cell tumour Urea cycle disorder Sarcoidosis Obliterative bronchiolitis Fungal infection Ovarian cancer stage III More trials…

    Learn about Rare Diseases

    Usher’s syndrome – Life with Disease Andersen-Tawil syndrome – Treatment Mucopolysaccharidosis I – Basic Information Lymphangioma – Treatment Rett syndrome – Life with Disease Cystic fibrosis lung – Diagnostics Systemic mastocytosis – Treatment Primary immunodeficiency syndrome – Treatment Idiopathic inflammatory myopathy – Life with Disease Antithrombin III deficiency More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    COLESEVELAM HYDROCHLORIDE Filgotinib Gen1047 Furosemide Ph. Eur. Vitamin A Bp Emicizumab Lanreotide Emraclidine Pentetic Acid Artemisia Vulgaris SURVODUTIDE Apocynin GRISNILIMAB SETARITOX Tremelimumab Nirmatrelvir Pegaspargase Lisdexamfetamine Dimesylate Solifenacin Succinate ZALFERMIN Ly3437943 Sodium More therapies…

    Learn about Your Condition

    Pelvic venous thrombosis Hepatitis D HER2 positive gastric cancer Marfan's syndrome Underweight Ebola disease Asthmatic crisis Alopecia areata Periarthritis Prader-Willi syndrome Prostatitis Escherichia coli Psychotic behaviour Restless legs syndrome Breast cancer in situ Pancreatic carcinoma stage IV More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on the Safety and Effects of Cipaglucosidase Alfa and Miglustat for Children with Infantile-onset Pompe Disease

    Recruiting

    3 1 1
    Investigated Diseases:
    • Glycogen storage disease type II
    Investigated Drugs:
    • Cipaglucosidase Alfa
    • Miglustat
    Denmark France Germany Italy The Netherlands

  • Study on Dostarlimab Immunotherapy for Patients with Localized Gastric Cancer with Deficient Mismatch Repair or High Microsatellite Instability

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Metastatic gastric cancer
    Investigated Drugs:
    • Dostarlimab
    France Italy

  • Study on Mepolizumab and Nasal Polypectomy for Patients with Chronic Rhinosinusitis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Chronic rhinosinusitis with nasal polyps
    Investigated Drugs:
    • Mepolizumab
    Spain

  • Study Comparing Chemoradiotherapy with Fluorouracil, Cisplatin, and Carboplatin for Patients with Operable Esophageal Squamous Cell Carcinoma

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Oesophageal squamous cell carcinoma
    Investigated Drugs:
    • Carboplatin
    • Cisplatin
    • Fluorouracil
    France Ireland Norway Sweden

  • Study on Baloxavir Marboxil for Children with Influenza

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Influenza
    Investigated Drugs:
    • Baloxavir Marboxil
    Bulgaria Poland Spain

  • Study of Pembrolizumab for Progressive Multifocal Leukoencephalopathy in Immunocompromised Patients Without HIV

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Progressive multifocal leukoencephalopathy
    Investigated Drugs:
    • Pembrolizumab
    France
Previous Page
1 … 539 540 541 542 543 … 1,655
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!